Agreed Starbeck. Huge news the last several weeks for CELZ. The Q should be very good and show revenue, and we know the trial results are due. Several doctors will be performing in short order, all the things a whale needs to feed.
$CELZ - It's the only OTC I have invested in where leadership never over promises and under delivers. If anything, they don't pump enough but with most of them doctors, not their thing.